ArticleOncotarget2018
The recent landscape of cancer research worldwide: a bibliometric and network analysis.
Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.
- The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review.Frontiers in pharmacology · 2023Pooled it
- Bibliometric Analysis of Global Research Activity on Stroke Mortality: 1961-2024.Neuroepidemiology · 2026Article
- A bibliometric and visualized analysis of CAR-T or TCR-T in solid tumor (from 2015 to 2024).Discover oncology · 2026Article
- Therapeutic Modulation of the Microbiome in Oncology: Current Trends and Future Directions.Current pharmaceutical biotechnology · 2025Review
- Using automated text classification to explore uncertainty in NICE appraisals for drugs for rare diseases.International journal of technology assessment in health care · 2024Article
- Data-driven information extraction and enrichment of molecular profiling data for cancer cell lines.Bioinformatics advances · 2024Article
- Sex and authorship in global cancer research.BMJ oncology · 2024Article
- Cancer Research in Vulnerable Populations: A Call for Collaboration and Sustainability From MENAT Countries.JCO global oncology · 2023Article
- Editorial - The Secret Life of Retractions in Scientific Publications.Principles and practice of clinical research (2015) · 2023Article
- General practice-based cancer research publications: a bibliometric analysis 2013-2019.The British journal of general practice : the journal of the Royal College of General Practitioners · 2023Observational
- The status of bladder cancer research worldwide, a bibliometric review and recommendations.Arab journal of urology · 2023Article
- Tops and Trends in Iranian Cancer Research: A Bibliometric Analysis.Archives of Iranian medicine · 2022Article
- Research Trends and Emerging Hotspots of Lung Cancer Surgery during 2012-2021: A 10-Year Bibliometric and Network Analysis.Health data science · 2022Article
- The top 100 most-cited papers in pheochromocytomas and paragangliomas: A bibliometric study.Frontiers in oncology · 2022Article
- Emerging Trends and Research Foci in Tumor Microenvironment of Pancreatic Cancer: A Bibliometric and Visualized Study.Frontiers in oncology · 2022Article
- Peptide-Assisted Nucleic Acid Delivery Systems on the Rise.International journal of molecular sciences · 2021Review
- The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research.The Lancet. Oncology · 2021Review
- The top 100 most-cited papers in long non-coding RNAs: a bibliometric study.Cancer biology & therapy · 2021Article
- Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients.Journal of oncology · 2021Article
- The 8th Symposium on Global Cancer Research: Recognizing Creativity and Collaboration to Support Global Cancer Research and Control.JCO global oncology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this paper is to map the scientific landscape related to cancer research worldwide between 2012 and 2017. We use scientific publication data from Web of Science Core Collection and combine bibliometrics and social network analysis techniques to identify the most relevant journals, research areas, countries and research organizations in cancer scientific landscape. The results show: Oncotarget as the journal with most publications; a significant increase in China's publications, reaching United States' publications in 2017; MD Cancer Center, University of California and Harvard University as organizations with most publications; cell biology as the most frequent research area; breast, lung and colorectal cancer as the most frequent keywords; high density of co-authorship between organizations in the West, especially in the US, and low density between organizations in Asian and lower and medium income countries. Our findings can be used to guide a global knowledge platform guiding policy, planning and funding decisions as well as to establish new institutional collaborations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.